Leqvio Injektionslösung

Leqvio Injektionslösung is a medicine authorised by Swissmedic under authorisation number 67836. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Transplant: gene therapy product and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 09 September 2021 and the authorisation is valid without a time limit. ATC code C10AX16 places the medicine in the group Lipid modifying agents.

  • Dispensing category B
  • Authorisation number 67836
  • ATC C10AX16
  • Transplant: gene therapy product
Authorisation data
Authorisation number67836
NameLeqvio Injektionslösung
Full nameLeqvio Injektionslösung
Authorisation holderNovartis Pharma Schweiz AG
Medicinal product codeTransplant: gene therapy product
Dispensing categoryB · Prescription only
ATC codeC10AX16
First authorisation09 September 2021
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Leqvio InjektionslösungB09 September 2021

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Fertigspritze(n)C10AX1607.12.0.B
21Fertigspritze(n)C10AX1607.12.0.B

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Leqvio Injektionslösung authorised in Switzerland?

Yes. Leqvio Injektionslösung is authorised by Swissmedic under authorisation number 67836, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Leqvio Injektionslösung have?

Leqvio Injektionslösung is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Leqvio Injektionslösung?

The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com